Amit Hazan
Stock Analyst at Goldman Sachs
(2.20)
# 2,484
Out of 4,820 analysts
95
Total ratings
56.25%
Success rate
1.33%
Average return
Main Sectors:
Stocks Rated by Amit Hazan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSP Inspire Medical Systems | Upgrades: Buy | n/a | $159.06 | - | 3 | Dec 13, 2022 | |
| BVS Bioventus | Maintains: Neutral | $13 → $2.5 | $7.69 | -67.49% | 5 | Nov 30, 2022 | |
| SKIN The Beauty Health Company | Maintains: Buy | $22 → $19 | $0.98 | +1,836.80% | 4 | Nov 23, 2022 | |
| SHC Sotera Health Company | Maintains: Neutral | $9 → $8 | $11.16 | -28.28% | 4 | Nov 23, 2022 | |
| LIVN LivaNova | Maintains: Buy | $73 → $63 | $37.25 | +69.13% | 3 | Nov 23, 2022 | |
| BDX Becton, Dickinson and Company | Maintains: Buy | $319 → $272 | $205.21 | +32.55% | 8 | Nov 23, 2022 | |
| BLCO Bausch + Lomb | Maintains: Neutral | $19 → $17 | $13.72 | +23.95% | 3 | Nov 23, 2022 | |
| OM Outset Medical | Maintains: Buy | $510 → $435 | $11.51 | +3,679.32% | 2 | Nov 9, 2022 | |
| PRCT PROCEPT BioRobotics | Maintains: Neutral | $39 → $44 | $52.49 | -16.17% | 2 | Nov 4, 2022 | |
| EW Edwards Lifesciences | Maintains: Neutral | $97 → $73 | $76.04 | -4.00% | 3 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $60 → $53 | $30.22 | +75.38% | 11 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $57 | $35.07 | +62.53% | 1 | Oct 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $11 → $9.5 | $11.51 | -17.43% | 2 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $111 → $104 | $128.85 | -19.29% | 7 | Jul 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $60 | $8.30 | +622.89% | 3 | Jul 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $129 → $115 | $84.16 | +36.64% | 9 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $248 → $150 | $365.70 | -58.98% | 2 | Apr 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $46 | $101.91 | -54.86% | 1 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $242 | $514.59 | -53.04% | 8 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $177 | $101.51 | +74.37% | 5 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $139 → $147 | $154.58 | -4.90% | 6 | Feb 25, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $3.5 → $3.9 | $1.57 | +148.41% | 3 | Nov 1, 2018 |
Inspire Medical Systems
Dec 13, 2022
Upgrades: Buy
Price Target: n/a
Current: $159.06
Upside: -
Bioventus
Nov 30, 2022
Maintains: Neutral
Price Target: $13 → $2.5
Current: $7.69
Upside: -67.49%
The Beauty Health Company
Nov 23, 2022
Maintains: Buy
Price Target: $22 → $19
Current: $0.98
Upside: +1,836.80%
Sotera Health Company
Nov 23, 2022
Maintains: Neutral
Price Target: $9 → $8
Current: $11.16
Upside: -28.28%
LivaNova
Nov 23, 2022
Maintains: Buy
Price Target: $73 → $63
Current: $37.25
Upside: +69.13%
Becton, Dickinson and Company
Nov 23, 2022
Maintains: Buy
Price Target: $319 → $272
Current: $205.21
Upside: +32.55%
Bausch + Lomb
Nov 23, 2022
Maintains: Neutral
Price Target: $19 → $17
Current: $13.72
Upside: +23.95%
Outset Medical
Nov 9, 2022
Maintains: Buy
Price Target: $510 → $435
Current: $11.51
Upside: +3,679.32%
PROCEPT BioRobotics
Nov 4, 2022
Maintains: Neutral
Price Target: $39 → $44
Current: $52.49
Upside: -16.17%
Edwards Lifesciences
Nov 3, 2022
Maintains: Neutral
Price Target: $97 → $73
Current: $76.04
Upside: -4.00%
Nov 3, 2022
Maintains: Sell
Price Target: $60 → $53
Current: $30.22
Upside: +75.38%
Oct 11, 2022
Initiates: Buy
Price Target: $57
Current: $35.07
Upside: +62.53%
Aug 8, 2022
Maintains: Neutral
Price Target: $11 → $9.5
Current: $11.51
Upside: -17.43%
Jul 25, 2022
Maintains: Sell
Price Target: $111 → $104
Current: $128.85
Upside: -19.29%
Jul 14, 2022
Maintains: Neutral
Price Target: $80 → $60
Current: $8.30
Upside: +622.89%
Jan 18, 2022
Maintains: Neutral
Price Target: $129 → $115
Current: $84.16
Upside: +36.64%
Apr 1, 2020
Downgrades: Sell
Price Target: $248 → $150
Current: $365.70
Upside: -58.98%
Feb 13, 2020
Initiates: Neutral
Price Target: $46
Current: $101.91
Upside: -54.86%
Feb 13, 2020
Initiates: Buy
Price Target: $242
Current: $514.59
Upside: -53.04%
Feb 13, 2020
Initiates: Buy
Price Target: $177
Current: $101.51
Upside: +74.37%
Feb 25, 2019
Maintains: Neutral
Price Target: $139 → $147
Current: $154.58
Upside: -4.90%
Nov 1, 2018
Upgrades: Neutral
Price Target: $3.5 → $3.9
Current: $1.57
Upside: +148.41%